Hallucinations and Hallucinogens: Psychopathology or Wisdom?
José Carlos Bouso, Genís Ona, Maja Kohek, Rafael G. Dos Santos, Jaime E. C. Hallak, Miguel Ángel Alcázar‐córcoles, Joan Obiols-Llandrich
Culture, Medicine, and Psychiatry June 1, 2023 DOI: 10.1007/s11013-022-09814-0 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Theoretical or philosophical paper Peer reviewed |
|---|---|
| Keywords | Hallucinations Hallucinogens Ontology Psychedelics Psychopathology Psychotherapy |
| Citations | 8 |
| Key points | Proposes that hallucinations are a common phenomenon that can be associated with beneficial outcomes and offer a pathway to knowledge, rather than solely indicating psychopathology. |
Abstract
Hallucinations are currently associated almost exclusively with psychopathological states. While it is evident that hallucinations can indicate psychopathology or neurological disorders, we should remember that hallucinations also commonly occur in people without any signs of psychopathology. A similar case occurs in the case of hallucinogenic drugs, which have been long associated with psychopathology and insanity. However, during the last decades a huge body of research has shown that certain kinds of hallucinations, exerted by hallucinogenic drugs, may serve to improve mental health. We propose that, in light of historical, epidemiological, and scientific research, hallucinations can be better characterized as a common phenomenon associated sometimes with psychopathology but also with functional and even beneficial outcomes. In the last sections of the manuscript, we extend our argument, suggesting that hallucinations can offer a via regia to knowledge of the mind and the world. This radical shift in the cultural interpretation of hallucinations could have several implications for fields such as drug policy, civil law, and psychiatry, as well as for the stigma associated with mental disorders.
Citations in the library
Cited by 4
- Longitudinal and transcultural assessment of the relationship between hallucinogens, well-being, and post-traumatic growth during the COVID-19 pandemic Scientific Reports September 11, 2023
- Psychedelic Drugs or Hallucinogens: Exploring Their Medicinal Potential. Cureus November 1, 2023
- Symmetrical Global Mental Health (Sym-GMH): Ayahuasca and shipibo traditional medicine for lasting changes in personality and quality of life Psychedelics April 20, 2026
- Enchanted consciousness revisited – Ayahuasca visualizations and Sartre's ideas on hallucination Journal of Psychedelic Studies March 9, 2026
Cites 71
- Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance Psychopharmacology July 7, 2006
- Human hallucinogen research: guidelines for safety. Journal of Psychopharmacology July 1, 2008
- Psilocybin induces schizophrenia-like psychosis in humans via a serotonin-2 agonist action Neuroreport December 1, 1998
- Safety, Tolerability, and Efficacy of Psilocybin in 9 Patients With Obsessive-Compulsive Disorder The Journal of Clinical Psychiatry November 15, 2006
- Salvinorin A: a potent naturally occurring nonnitrogenous kappa opioid selective agonist. Proceedings of the National Academy of Sciences September 3, 2002
and 66 more in the library